Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated TMS for Perinatal Depression

NCT: NCT06968390 · RECRUITING

NCT IDNCT06968390
StatusRECRUITING
Start Date2025-08-05
Completion2028-07
SponsorBrigham and Women's Hospital (OTHER)
First posted
Last updated

Brief Summary

We are studying a treatment for depression called accelerated Transcranial Magnetic Stimulation (TMS) among pregnant and postpartum individuals. TMS is a focal, non-invasive form of brain stimulation that is cleared by the Food and Drug Administration for depression. Typically, traditional TMS involves daily treatments for 6-8 weeks. In this study, we will offer an accelerated form of TMS that involves multiple daily treatments for 5 days.

Frequently Asked Questions

What is Accelerated TMS for Perinatal Depression?

Accelerated TMS for Perinatal Depression is a clinical trial registered under NCT06968390. Current status: RECRUITING.

What is the status of NCT06968390?

The current status of NCT06968390 (Accelerated TMS for Perinatal Depression) is: RECRUITING.

When did Accelerated TMS for Perinatal Depression start?

Accelerated TMS for Perinatal Depression started on 2025-08-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.